Breast Cancer

Article	Citations
Adipose-derived stem cells enhance the tumorigenic potential of pre-malignant breast epithelial cells through paracrine activation of PI3K–AKT pathway	123
Validation of late recurrence prediction by gene expression profiles and clinicopathological factors in estrogen receptor-positive breast cancer	48
Deciphering the nexus between the tumor immune microenvironment and DNA methylation in subgrouping estrogen receptor-positive breast cancer	40
Exploration of treatment strategies and susceptibility gene of postoperative nausea and vomiting in breast cancer patients: a randomised controlled trial	34
Quality of life and satisfaction of patients after oncoplastic or traditional breast-conserving surgery using the BREAST-Q (BCT module): a prospective study	32
CD1a- and CD83-positive dendritic cells as prognostic markers of metastasis development in early breast cancer patients	31
Long-term local control and cosmesis of perioperative interstitial brachytherapy for partial breast irradiation following breast-conserving surgery	29
A prospective cohort study of abemaciclib-induced interstitial lung disease in metastatic breast cancer after chemotherapy	27
Correction: Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and/or leptomeningeal metastases: an updated overall survival analysis using data from a mu	26
Impact of breast size and composition on the accuracy of mammography and ultrasonography in breast cancer screening	26
Correction to: The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition	24
Development of a nomogram to predict recurrence scores obtained using Oncotype DX in Japanese patients with breast cancer	23
Case series of Li-Fraumeni syndrome: carcinogenic mechanisms in breast cancer with TP53 pathogenic variant carriers	22
Clinical outcomes after post-operative radiotherapy for breast cancer patients presenting with ipsilateral supraclavicular metastasis: considerations on the cranial border of irradiation field	20
Does axillary lymph node recurrence breast cancer subtype information matter for prognosis estimation?	20
Hub metastatic gene signature and risk score of breast cancer patients with small tumor sizes using WGCNA	20
Survival in patients with rheumatoid arthritis and early breast cancer treated with tumor necrosis factor inhibitors	20
An insight into the role of innate immune cells in breast tumor microenvironment	19
A genome-wide CRISPR/Cas9 knockout screen identifies SEMA3F gene for resistance to cyclin-dependent kinase 4 and 6 inhibitors in breast cancer	19
Clinicopathogenomic analysis of PI3K/AKT/PTEN-altered luminal metastatic breast cancer in Japan	18
Biology of primary breast cancer in older women beyond routine biomarkers	18
A 5-year review of genomic medicine in breast cancer: insights from C-CAT data on 3776 Japanese patients	18
Japanese subpopulation analysis of MONARCH 2: phase 3 study of abemaciclib plus fulvestrant for treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer	17
Integrated analysis of cell cycle-related genes in HR+/HER2− breast cancer	17
The safety of performing breast reconstruction during the COVID-19 pandemic	15

Single HER2-positive tumor cells are detected in initially HER2-negative breast carcinomas using the DEPArray™–HER2-FISH workflow	14
Effect of Apatinib plus melatonin on vasculogenic mimicry formation by cancer stem cells from breast cancer cell line	14
A systematic review of behaviour change techniques used in interventions to increase physical activity among breast cancer survivors	13
Quality of life improvement in breast cancer survivors affected by upper limb lymphedema through a novel multiperspective physical activity methodology: a monocentric pilot study	13
Identification of key tumor stroma-associated transcriptional signatures correlated with survival prognosis and tumor progression in breast cancer	13
Surgical treatment trends and identification of primary breast tumors after surgery in occult breast cancer: a study based on the Japanese National Clinical Database—Breast Cancer Registry	13
Identifying ductal carcinoma in situ cases not requiring surgery to exclude postoperative upgrade to invasive ductal carcinoma	12
The hub ten gene-based risk score system using RNA m6A methylation regulator features and tumor immune microenvironment in breast cancer	12
Incidence of and risk factors for non-hematologic toxicity with combined radiotherapy and CDK4/6 inhibitors in metastatic breast cancer using dose-volume parameters analysis: a multicenter cohort stud	11
The association of infectious mononucleosis and invasive breast cancer in The Health of Women (HOW) Study®	11
Diagnostic performance of dedicated breast positron emission tomography	11
Prognostic effect of subsequent childbirth after the diagnosis of breast cancer using propensity score matching analysis	11
Sensitivity and specificity of screening mammography without clinical breast examination among Japanese women aged 40–49 years: analysis of data from the J-START results	11
Significance of prostate/pancreatic/skin cancer family history for detecting BRCA2 pathogenic variant careers among patients with breast cancer	10
A novel ADC targeting cell surface fibromodulin in a mouse model of triple-negative breast cancer	10
Effects of exercise on cancer-related cognitive impairment in breast cancer survivors: a scoping review	10
Development and implementation of a decision aid for post-mastectomy breast reconstruction for Japanese women with breast cancer: a field-testing study	10
Cell-free biomimetic polyurethane-based scaffold for breast reconstruction following non-malignant lesion resection. A first-in-human study	10
miR-145, miR-205 and miR-451: potential tumor suppressors involved in the progression of in situ to invasive carcinoma of the breast	10
Clinical outcome of patients with isolated central nervous system progression on first-line pertuzumab and trastuzumab treatment for HER2-positive metastatic breast cancer in a real-life cohort	10
Validation of a nuclear grading system for resected stage I–IIIA, high-risk, node-negative invasive breast carcinoma in the N·SAS-BC 01 trial	10
Copy number alteration is an independent prognostic biomarker in triple-negative breast cancer patients	10
Prognosis of post-neoadjuvant therapy patients who underwent immediate breast reconstruction: a SEER-based, propensity-matched study	9
2020 Annual Report of National Clinical Database-Breast Cancer Registry: 10-year mortality of elderly breast cancer patients in Japan	9
Assessment of nuclear grade-based recurrence risk classification in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative, node-positive high-risk early breast can	9
Machine learning applied in patient-reported outcome research—exploring symptoms in adjuvant treatment of breast cancer	9
The Japanese Breast Cancer Society Clinical Practice Guidelines for surgical treatment of breast cancer, 2022 edition	9
Reply to “Is venous thromboembolism a time-dependent event in breast cancer patients taking tamoxifen?”	9
Prevalent landscape of tumor genomic alterations of luminal B1 breast cancers using a comprehensive genomic profiling assay in Taiwan	9
Delayed breast reconstruction with autologous free flap after radiation therapy: vascular complications and aesthetic outcomes	8
The influence of a previous implant-based breast reconstruction on postoperative sensation of the deep inferior epigastric artery perforator flap	8
Antitumor effects of co-treatment of resveratrol with antitumor drugs in ER- and HER2-positive breast cancer cells are due to induction of apoptosis and modulation of estrogen receptor expression	8
Clinicopathologic and genetic features of metaplastic breast cancer with osseous differentiation: a series of 6 cases	8
Medical care costs according to the stage and subtype of breast cancer in a municipal setting: a case study of Hachioji City, Japan	8
Identification and validation of screening models for breast cancer with 3 serum miRNAs in an 11,349 samples mixed cohort	8
New variant of breast-invasive lobular carcinoma with solid and encapsulated papillary carcinoma growth pattern	8
Advances in the study of autophagy in breast cancer	8
Number of lines of previous chemotherapy regimen might affect the oucome of sacituzumab govitecan in metastatic triple-negative breast cancer patients	8
Performance analysis of screening mammography in Asian women under 40 years	8
Average lifespan shortened due to breast cancer in Australia, 1990–2015	7
Pathologic complete response and survival in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy	7
Comparison of short-term outcomes between pedicled- and free-flap autologous breast reconstruction: a nationwide inpatient database study in Japan	7
Psychometric evaluation of the Chinese version of the breast cancer perception scale for community women: a translation and validation study	7
Correction: Clinicopathological significance of androgen receptor expression and tumor infiltrating lymphocytes in triple-negative breast cancer: a retrospective cohort study	7
Acknowledgments to reviewers 2022	7
Conservative axillary surgery is emerging in the surgical management of breast cancer	7
Identification of prognostic genes signature and construction of ceRNA network in pirarubicin treatment of triple-negative breast cancer	7
Defer surgery in operable breast cancer: how long is too long?	7
Predictors of delayed breast reconstruction in the Netherlands: a 5-year follow-up study in stage I–III breast cancer patients	7
Interactions between exposure to polycyclic aromatic hydrocarbons and xenobiotic metabolism genes, and risk of breast cancer	7

Effectiveness of eribulin as first-line or second-line chemotherapy for HER2-negative hormone-resistant advanced or metastatic breast cancer: findings from the multi-institutional, prospective, observ	7
Clinical outcomes and patient satisfaction with the use of biological and synthetic meshes in one-stage implant-based breast reconstruction	6
A risk scoring system based on tumor microenvironment cells to predict prognosis and immune activity in triple-negative breast cancer	6
BAP1-defficient breast cancer in a patient with BAP1 cancer syndrome	6
Acknowledgments to reviewers 2024	6
Community-based outpatient rehabilitation for the treatment of breast cancer-related upper extremity disability: an evaluation of practice-based evidence	6
Development and internal validation of a predictive model of overall and progression-free survival in eribulin-treated patients with breast cancer based on baseline peripheral blood parameters	6
Identifying women with increased risk of breast cancer and implementing risk-reducing strategies and supplemental imaging	6
Association of lymphatic flow velocity with surgical outcomes in patients undergoing lymphovenous anastomosis for breast cancer-related lymphedema	6
Overexpression of MCAM induced by SMYD2-H3K36me2 in breast cancer stem cell properties	6
Risk factors for arm lymphedema following breast cancer surgery: a Japanese nationwide database study of 84,022 patients	6
A novel formula to improve the accuracy and prognostic ability of determining the survival time after recurrent breast cancer	6
Beneficial effects of transdermal administration of tamoxifen on capsular contracture after breast implantation in murine models	6
Integrin β1 in breast cancer: mechanisms of progression and therapy	6
Live-attenuated poliovirus-induced extrinsic apoptosis through Caspase 8 within breast cancer cell lines expressing CD155	6
Long-term prognostic value of the GenesWell BCT score in Asian women with hormone receptor-positive/HER2-negative early breast cancer	5
Are breast cancer subtypes different in breast cancer patients with and without hepatitis C virus infection?	5
Neurospora crassa is a potential source of anti-cancer agents against breast cancer	5
Correction to: The effectiveness of moisturizer on acute radiation-induced dermatitis in breast cancer patients: a systematic review and meta-analysis	5
Impact of oral hygiene on febrile neutropenia during breast cancer chemotherapy	5
Deep learning model with collage images for the segmentation of dedicated breast positron emission tomography images	5
The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment	5
Liquid biopsy for breast cancer and other solid tumors: a review of recent advances	5
Omission of adjuvant radiotherapy in low-risk elderly males with breast cancer	5
Outcomes of whole breast radiation therapy in Asian breast cancer patients with prior cosmetic implants	5
The transverse myocutaneous gracilis flap (TMG) for breast reconstruction: ipsi vs. contralateral harvest—aesthetic outcome and refinement procedures	5
Association of psychological distress with arm morbidity symptoms in breast cancer survivors: outcomes from the use of PHQ-9 and GAD-7 questionnaires	5
Oncoplastic versus conventional breast-conserving surgery in breast cancer: a pooled analysis of 6941 female patients	5
miR-4796 enhances the sensitivity of breast cancer cells to ionising radiation by impairing the DNA repair pathway	5
Radiation-induced angiosarcoma of the breast: retrospective analysis at a regional treatment centre	5
The effectiveness of moisturizer on acute radiation-induced dermatitis in breast cancer patients: a systematic review and meta-analysis	5
Expression and clinical significance of hypoxia-induced long non-coding RNA TCONS_I2_00001955 in breast cancer	5
Fatigue and quality of life during neoadjuvant chemotherapy of early breast cancer: a prospective multicenter cohort study	5
An integrated analysis of microRNAs regulating DNA damage response in triple-negative breast cancer	5
Dynamic network biomarker to determine the critical point of breast cancer stage progression	5
Neoadjuvant chemotherapy using nanoparticle albumin-bound paclitaxel plus trastuzumab and pertuzumab followed by epirubicin and cyclophosphamide for operable HER2-positive primary breast cancer: a mul	5
Assessment of the cardiorespiratory fitness and the quality of life of patients with breast cancer undergoing chemotherapy: a prospective study	5
Correction: The Japanese breast cancer society clinical practice guidelines for breast cancer screening and diagnosis, 2022 edition	5
Quality of life in a randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer	5
Patient-reported outcomes of mesh in minimally invasive (laparoscopic/robot-assisted) immediate subpectoral prosthesis breast reconstruction: a retrospective study	4
The effect of exercise and educational programs for breast cancer patients on the development of breast cancer-related lymphoedema: secondary endpoint from a randomized controlled trial in the Setouch	4
Correction: The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment	4
Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within T2N1M0 stage hormone receptor-positive, HER2-negative breast cancer: a retrospective cohort study based on SEER databas	4
The complex role of regulatory cells in breast cancer: implication for immunopathogenesis and immunotherapy	4
What affects women’s decision-making on breast reconstruction after mastectomy for breast cancer?	4
Economic impact of screening on postdiagnosis work productivity in Japanese women with breast cancer: a life-table modeling approach	4
SLC38A5 promotes glutamine metabolism and inhibits cisplatin chemosensitivity in breast cancer	4
Correction to: Racial and socioeconomic inequities in breast cancer screening before and during the COVID-19 pandemic: analysis of two cohorts of women 50 years +	4
Microsurgical techniques in the treatment of breast cancer-related lymphedema: a systematic review of efficacy and patient outcomes	4
Comparisons of postoperative outcomes after breast cancer surgery in patients with and without renal replacement therapy: a matched-pair cohort study using a Japanese nationwide inpatient database	4
Role of circulating tumor cells in breast cancer	4
Interleukin (IL)-17A in triple-negative breast cancer: a potent prognostic factor associated with intratumoral neutrophil infiltration	4
Refining the role of surgery in de novo stage IV breast cancer: the need for biomarkers and mechanistic insights	4
A message from the new editor-in-chief	4
Efficacy and safety of adjuvant therapies in older patients with breast cancer: a systematic review and meta-analysis of real-world data	4
Breast-conserving surgery versus modified radical mastectomy in T1-2N3M0 stage breast cancer: a propensity score matching analysis	4
Breast cancer epigenetics: current and evolving treatment	4
Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within breast cancer subtypes and stages among older women: a SEER-Medicare analysis	4
Factors associated with post acute care utilization after mastectomy for breast cancer patients	4
Artificial intelligence computer-aided detection enhances synthesized mammograms: comparison with original digital mammograms alone and in combination with tomosynthesis images in an experimental sett	4
A novel nomogram and survival analysis for different lymph node status in breast cancer based on the SEER database	4
Correction to: Validation of a nuclear grading system for resected stage I–IIIA, high-risk, node-negative invasive breast carcinoma in the N·SAS-BC 01 trial	4
Correction to: The Japanese Breast Cancer Society clinical practice guidelines for surgical treatment of breast cancer, 2018 edition	4
Prevalence of mutations in BRCA and homologous recombination repair genes and real-world standard of care of Asian patients with HER2-negative metastatic breast cancer starting first-line systemic cyt	4
Gut microbiota and breast cancer: systematic review and meta-analysis	4
An increase in tumor-infiltrating lymphocytes after treatment is significantly associated with a poor response to neoadjuvant endocrine therapy for estrogen receptor-positive/HER2-negative breast canc	4
The Japanese breast cancer society clinical practice guidelines for radiation treatment of breast cancer, 2022 edition	4
Genetic medicine is accelerating in Japan	4
Real-world data of HER2-negative early breast cancer patients treated with anthracycline and/or taxane regimens in Japan	4
Management of nausea and vomiting induced by antibody–drug conjugates	4
Adjuvant chemotherapy in T1a/bN0 breast cancer with a high 21-gene recurrence score (> 25): a 10-year follow-up in a real-world cohort	4
Predictors of persistent post-surgical pain intensity and interference at 1 year after breast cancer surgery: assessing central sensitization, central sensitivity symptoms, and psychological factors	4
Global untargeted and individual targeted plasma metabolomics of breast cancer recurrence modified by hormone receptors	4
Real-world incidence of and risk factors for abemaciclib-induced interstitial lung disease in Japan: a nested case–control study of abemaciclib-induced interstitial lung disease (NOSIDE)	4
Correction to: Quality of life in a randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer	4
Multi-time scale transcriptomic analysis on the dynamic process of tamoxifen resistance development in breast cancer cell lines	4
The transverse musculocutaneous gracilis flap for autologous breast reconstruction: focus on donor site morbidity	4
Acute adverse events of ultra-hypofractionated whole-breast irradiation after breast-conserving surgery for early breast cancer in Japan: an interim analysis of the multi-institutional phase II UPBEAT	4
Efficacy and feasibility of neoadjuvant pembrolizumab plus chemotherapy for early-stage triple-negative and estrogen receptor low, HER2-negative breast cancer: a Japanese single-institution real-world	4
The role of C1orf50 in breast cancer progression and prognosis	4

Impact of adjuvant endocrine therapy on prognosis in small hormone receptor-positive, HER2-negative early breast cancer	3
A randomized trial of the impact of symptom monitoring using an electronic patient-reported outcome app on health-related quality of life in postmenopausal breast cancer patients receiving adjuvant en	3
Predictive factors for response to neoadjuvant chemotherapy: inflammatory and immune markers in triple-negative breast cancer	3
Options of locoregional therapy for primary foci of breast cancer influence the rate of nonregional lymph node metastasis in N2–N3 status patients: a SEER database analysis	3
Association between quality of life and mortality risk in patients with breast cancer: a systematic review and meta-analysis	3
Mesenchymal-like immune-altered is the fourth robust triple-negative breast cancer molecular subtype	3
Population-level impact of adjuvant trastuzumab emtansine on the incidence of metastatic breast cancer: an epidemiological prediction model of women with HER2-positive early breast cancer and residual	3
Venous thromboembolism in Japanese patients with breast cancer: subgroup analysis of the Cancer-VTE Registry	3
The collagenase of the bacterium Clostridium histolyticum does not favor metastasis of breast cancer	3
FOXA1 of regulatory variant associated with risk of breast cancer through allele-specific enhancer in the Chinese population	3
The involvement of axillary reverse mapping nodes in patients with clinically node-negative breast cancer	3
Immune-related biomarkers in triple-negative breast cancer	3
Investigation of recurrence prediction ability of EndoPredict® using microarray data from fresh frozen tissues in ER-positive, HER2-negative breast cancer and indication expansion of EndoPredict® from	3
Correction: Programmed death ligand 1-positive immune cells in primary tumor or metastatic axillary lymph nodes can predict prognosis of triple-negative breast cancer even when present at < 1% in t	3
Ex vivo dual gene therapy using human adipocytes secreting anti-HER2 antibody on HER2-positive xenograft tumor models	3
Evaluation of quality of life in breast cancer patients who underwent breast-conserving surgery or mastectomy using real-world data	3
High-risk pathogenic germline variants in blood relatives of BRCA1/2 negative probands	3
Risk of primary lung cancer after breast cancer radiotherapy: a systematic review and meta-analysis	3
Follow-up of tissue genomics in BRCA1/2 carriers who underwent prophylactic surgeries	3
Axillary dissection versus axillary observation for low risk, clinically node-negative invasive breast cancer: a systematic review and meta-analysis	3
Mixed ductal–lobular carcinoma: an analysis of CDH1 DNA copy number variation and mutation	3
Trastuzumab deruxtecan versus treatment of physician’s choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study	3
Liquid biopsy using non-coding RNAs and extracellular vesicles for breast cancer management	3
Effectiveness and tasks of breast MRI surveillance for high-risk women with cancer susceptibility genes other than BRCA1/2: a single institution study	3
Survival advantage of locoregional and systemic therapy in oligometastatic breast cancer: an international retrospective cohort study (OLIGO-BC1)	3
Comparison of water- vs. land-based exercise for improving functional capacity and quality of life in patients living with and beyond breast cancer (the AQUA-FiT study): a randomized controlled trial	3
Relevance of the MHC region for breast cancer susceptibility in Asians	3
Japanese subgroup analysis of the phase 3 MONARCH 3 study of abemaciclib as initial therapy for patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced brea	3
Correction to: Challenges and future directions in breast cancer care in Fukushima prefecture in Japan: correspondence to “A survey on the current status of clinical resources for diagnosis and treatm	3
Diagnostic accuracy of pre-operative breast magnetic resonance imaging (MRI) in predicting axillary lymph node metastasis: variations in intrinsic subtypes, and strategy to improve negative predictive	2
Comprehensive Young Age Breast Cancer registry from clinical, genomics, and patient-reported outcomes measured with 15 years follow-up: the CHARM cohort profile	2
Initial experience with targeted axillary dissection after neoadjuvant therapy in breast cancer patients	2
Serotonin 5-HT7 receptor is a biomarker poor prognostic factor and induces proliferation of triple-negative breast cancer cells through FOXM1	2
Non-irradiated area of intraoperative radiotherapy with electron technique: outcomes and pattern of failure in early-stage breast cancer from a single-center, registry study	2
Correction: Comparative assessment of breast volume using a smartphone device versus MRI	2
Dietary intake of branched-chain amino acids in relation to the risk of breast cancer	2
Resilience’s impact on quality of life and post-traumatic growth in breast cancer patients during treatment	2
Repeated sentinel lymph node biopsy for local recurrence after breast-conserving surgery	2
The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2022 edition	2
Clinicopathological significance of androgen receptor expression and tumor infiltrating lymphocytes in triple-negative breast cancer: a retrospective cohort study	2
French national survey on breast cancer care: caregiver and patient views	2
ER–/PR+ breast cancer is controlled more effectively with an inflammatory inhibitor than hormonal inhibitor	2
The effects of breast density on the benefits of mammograms with adjunctive ultrasonography in breast screening	2
HER2-targeted antibody–drug conjugates for breast cancer: ancestry and dose adjustment for thrombocytopenia	2
Enhancing radiosensitivity in triple-negative breast cancer through targeting ELOB	2
Importance of circulating tumor DNA analysis at diagnosis in early triple-negative breast cancer patients	2
Impact of immediate breast reconstruction on perioperative therapy: insights from a Japanese Nationwide Registry	2
Severity and risk factors of interval breast cancer in Queensland, Australia: a population-based study	2
Impact of serum vitamin D on the response and prognosis in breast cancer patients treated with neoadjuvant chemotherapy	2
Characterization of protein-based risk signature to predict prognosis and evaluate the tumor immune environment in breast cancer	2
Single-cell profile of tumor and immune cells in primary breast cancer, sentinel lymph node, and metastatic lymph node	2
Predictive value of immune genomic signatures from breast cancer cohorts containing data for both response to neoadjuvant chemotherapy and prognosis after surgery	2
Physicians’ perception about the impact of breast reconstruction on patient prognosis: a survey in Japan	2
Patient preferences for features of HER2-targeted treatment of advanced or metastatic breast cancer: a discrete-choice experiment study	2
Contemporaneous changes in cytokines and cognitive function during chemotherapy in patients with breast cancer: a prospective follow-up study	2
Patterns of treatment and their outcomes in primary breast lymphoma; a comprehensive population-based analysis	2
Racial differences in predictive value of the 21-gene recurrence score assay: a population-based study using the SEER database	2
CD68 and CD83 immune populations in non-metastatic axillary lymph nodes are of prognostic value for the survival and relapse of breast cancer patients	2
Postoperative cholesterol changes as early predictors of breast cancer-related lymphedema: a retrospective cohort study	2
Genitourinary symptoms in women with breast cancer: what do oncology health professionals think and do about them?	2
Reliability and validity of the Japanese version of the Chemotherapy-induced Alopecia Distress Scale	2
Survival trends and patient characteristics between 2004 and 2016 for breast cancer in Japan based on the National Clinical Database-Breast Cancer Registry	2
Hepatitis C virus may accelerate breast cancer progression by increasing mutant p53 and c-Myc oncoproteins circulating levels	2
Prognosis difference between HER2-low and HER2-zero breast cancer patients: a systematic review and meta-analysis	2
Factors associated with non-participation in breast cancer screening: analysis of the 2016 and 2019 comprehensive survey of living conditions in Japan	2
The impact of axillary lymph-node dissection omission on adjuvant abemaciclib eligibility in HR-positive, HER2-negative breast cancer with positive sentinel lymph nodes	2
Adverse effects of tamoxifen treatment on bone mineral density in premenopausal patients with breast cancer: a systematic review and meta-analysis	2
Phase 1 study of oral selective estrogen receptor degrader (SERD) amcenestrant (SAR439859), in Japanese women with ER-positive and HER2-negative advanced breast cancer (AMEERA-2)	2
Glutaminase (GLS1) gene expression in primary breast cancer	2
Increased breast cancer mortality due to treatment delay and needle biopsy type: a retrospective analysis of SEER-medicare	2
Factors affecting prognosis in patients treated with bevacizumab plus paclitaxel as first-line chemotherapy for HER2-negative metastatic breast cancer: an international pooled analysis of individual p	2
Racial and socioeconomic inequities in breast cancer screening before and during the COVID-19 pandemic: analysis of two cohorts of women 50 years +	2
LncRNA FOXD3-AS1 promotes breast cancer progression by mediating ARF6	2
Returning individual genomic results to population-based cohort study participants with BRCA1/2 pathogenic variants	2
Development and validation of a neoadjuvant chemotherapy pathological complete remission model based on Reg IV expression in breast cancer tissues: a clinical retrospective study	2
Phytochemical-conjugated bio-safe gold nanoparticles in breast cancer: a comprehensive update	2
Efficacy and safety of surgical energy devices for axillary node dissection: a systematic review and network meta-analysis	2
Endoscopic mastectomy followed by immediate breast reconstruction with fat grafting for breast cancer	2
Breast cancer screening rates and influencing factors among LGBTQ groups in Japan	2
SET-binding protein 1 (SETBP1) suppresses cell proliferation in estrogen receptor-positive breast cancer	2
Pilot trial of an electronic patient-reported outcome monitoring system in patients with metastatic breast cancer undergoing chemotherapy	2
Development and validation of a symptom illustration scale from the patient-reported outcome common terminology criteria for adverse events for patients with breast cancer	2
The frequency of low HER2 expression in breast cancer and a comparison of prognosis between patients with HER2-low and HER2-negative breast cancer by HR status	2
Clinical utility of tumor-infiltrating lymphocyte evaluation by two different methods in breast cancer patients treated with neoadjuvant chemotherapy	2
Can breast MRI and adjunctive Doppler ultrasound improve the accuracy of predicting pathological complete response after neoadjuvant chemotherapy?	2
Rethinking screening mammography in Japan: next-generation breast cancer screening through breast awareness and supplemental ultrasonography	2
Specific types of anxiety regarding radiation therapy in patients with breast cancer: a longitudinal study	2